A dietary change may make the fatal brain cancer glioblastoma more vulnerable to cancer therapies, a new study suggests. The researchers behind the work
Baxdrostat May Lower Systolic BP in CKD With Uncontrolled Hypertension
A phase 2 trial finds that baxdrostat, an aldosterone synthase inhibitor, meaningfully reduces systolic blood pressure (SBP) in patients with chronic kidney disease (CKD)
5 simple workouts to exercise your calf muscles
One of the easiest calf exercises that you can do anywhere- in the bathroom, in the train, or even in the office is standing
CoreWeave Stock Climbs 5% After $6.3B Cloud Capacity Deal with Nvidia
CoreWeave (CRWV) were higher by about 5% in early U.S. trading Monday after the cloud computing company entered into a $6.3 billion deal with
Why are stocks setting records when the economy feels down in the dumps?
Email Link Copied! Hiring is at a standstill. Inflation is on the rise again. Consumer sentiment is slipping near historic lows. Americans are increasingly
Elon Musk buys $1 billion worth of Tesla stock
Elon Musk responded to an unprecedented pay proposal from Tesla Inc.’s board by buying about $1 billion worth of shares, sending the stock soaring
Dow Jones Today: Stock Futures Higher With Fed Meeting on Deck; Nvidia Falls on China Tensions
U.S. stocks rose in early trading on Monday as the U.S. and China held trade talks and investors looked ahead to this week’s interest
Dodgers star Ohtani’s lawyers claim he was victim of likeness misuse in real estate deal, move to dismiss lawsuit
HONOLULU — Dodgers star Shohei Ohtani and his agent, Nez Balelo, moved to dismiss a lawsuit filed last month accusing them of causing a
Mortgage rates rise to 6.125% for 30-year loans: What it means for buyers
Today’s mortgage rates are ticking upward again. With 30-year fixed rates now at 6.125%, many buyers are rethinking how—and when—to finance their next home.
Triple-strength 'mega-dose' of weight loss jab could soon be available after breakthrough trial
Just a few months after it was made available on the NHS, a triple-strength dose of Wegovy could be rolled out, which could lead